Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 2Urinary Bladder, Neurogenic 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Small Cell Lung Carcinoma 1Pancreatic Neoplasms 1Malnutrition 1Head and Neck Neoplasms 1Esophagitis 1Endometriosis 1Cystitis, Interstitial 1Cystitis, Hemorrhagic 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 115Carboplatin 103Pemetrexed 90Cisplatin 58Paclitaxel 47osimertinib 40Drug Therapy 40Nivolumab 39Docetaxel 35Specimen Handling 33Magnetic Resonance Spectroscopy 28Bevacizumab 26durvalumab 23Gemcitabine 22cemiplimab 21Radiotherapy 20130-nm albumin-bound paclitaxel 20Radiosurgery 19tislelizumab 18atezolizumab 17aflutinib 15Cetuximab 15Immunotherapy 14Immune Checkpoint Inhibitors 14Platinum Compounds 13Ipilimumab 13Biopsy 12Standard of Care 11Surgical Procedures, Operative 10Injections 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Non-Small-Cell Lung × Immunonutrition Diet × Clear all
NCT06840704 2026-04-02

Relief

Hunan Cancer Hospital

Phase 3 Recruiting
121 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Esophagitis, Small Cell Lung Carcinoma

NCT05384873 2025-05-01

MURAL

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase NA Recruiting
180 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡